First generation mouse models of mtDNA disease: Testing genotype/phenotype predictions
第一代线粒体DNA疾病小鼠模型:测试基因型/表型预测
基本信息
- 批准号:nhmrc : 145719
- 负责人:
- 金额:$ 17.11万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2001
- 资助国家:澳大利亚
- 起止时间:2001-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mitochondrial diseases comprise a diverse group of inherited diseases affecting infants, children and adults. These disorders result from defective energy production by the mitochondria, tiny structures in all cells which have their own unique DNA. This mitochondrial DNA is inherited only from our mothers. To make energy for cells to function normally, special enzymes are produced in the mitochondria from mitochondrial and nuclear genes. In their most severe form mitochondrial disease results in infants with muti-system failure. Adult forms are less severe, with symptoms including epilepsy, cardiomyopathy, late-onset blindness or deafness, and commonly diabetes. We do not understand why different mitochondrial mutations result in such diverse symptoms, and no therapies have been consistently successful. Unusual features of mitochondrial DNA has meant that it has remained beyond the reach of techniques which are commonly used now to produce mice with altered genes. These so-called 'mouse models' are powerful tools to better understand human diseases and importantly, to enable experimental therapies to be tested and improved. This grant proposes a novel method of producing such mouse models, for the first time allowing mice with different levels of defective mitochondrial function to be produced to model the human diseases. In the proposed work, mitochondria from different mouse species will be introduced into laboratory mice. This unusual approach is based on previous work by the investigators who have shown that this produces defective mitochondria in cultured mouse cells. These mice will be allowed to age and the function of mitochondria from different organs tested as the animals age. Secondly, a range of mitochondrial DNA mutations will be produced in cultured cells and mutants selected to make other mice which should accurately model the diverse human diseases.
线粒体疾病包括影响婴儿、儿童和成人的多种遗传性疾病。这些疾病是由线粒体能量产生缺陷造成的,线粒体是所有细胞中具有独特 DNA 的微小结构。这种线粒体 DNA 仅遗传自我们的母亲。为了为细胞正常运作提供能量,线粒体和核基因会在线粒体中产生特殊的酶。最严重的线粒体疾病会导致婴儿多系统衰竭。成人形式不太严重,症状包括癫痫、心肌病、迟发性失明或耳聋,通常还伴有糖尿病。我们不明白为什么不同的线粒体突变会导致如此不同的症状,并且没有任何治疗方法能够持续成功。线粒体DNA的不寻常特征意味着它仍然超出了目前普遍用于生产基因改变小鼠的技术的能力范围。这些所谓的“小鼠模型”是更好地了解人类疾病的强大工具,更重要的是,可以测试和改进实验疗法。这项资助提出了一种生产此类小鼠模型的新方法,首次允许生产具有不同水平线粒体功能缺陷的小鼠来模拟人类疾病。在拟议的工作中,来自不同小鼠物种的线粒体将被引入实验室小鼠体内。这种不寻常的方法是基于研究人员之前的工作,他们已经证明这会在培养的小鼠细胞中产生有缺陷的线粒体。这些小鼠将被允许老化,并随着动物年龄的增长测试不同器官的线粒体功能。其次,一系列线粒体 DNA 突变将在培养细胞中产生,并选择突变体来制造其他小鼠,从而准确模拟各种人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A/Pr Ian Trounce其他文献
A/Pr Ian Trounce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A/Pr Ian Trounce', 18)}}的其他基金
OXPHOS upregulation to preserve vision in Leber's Hereditary Optic Neuropathy
OXPHOS 上调可保护莱伯遗传性视神经病患者的视力
- 批准号:
nhmrc : 1061472 - 财政年份:2014
- 资助金额:
$ 17.11万 - 项目类别:
Project Grants
Understanding mitochondrial DNA segregation and transmission.
了解线粒体 DNA 分离和传输。
- 批准号:
nhmrc : 1041471 - 财政年份:2013
- 资助金额:
$ 17.11万 - 项目类别:
Project Grants
Boosting mitochondria- a new approach for protecting the aging optic nerve in glaucoma
增强线粒体——保护青光眼老化视神经的新方法
- 批准号:
nhmrc : 1033506 - 财政年份:2012
- 资助金额:
$ 17.11万 - 项目类别:
Project Grants
How does glucose protect the retina and optic nerve against ischaemia?
葡萄糖如何保护视网膜和视神经免受缺血?
- 批准号:
nhmrc : 626964 - 财政年份:2010
- 资助金额:
$ 17.11万 - 项目类别:
NHMRC Project Grants
Neurodegenerative diseases of the ageing brain: diagnosis & therapy based on the study of aggregated protein deposition
衰老大脑的神经退行性疾病:诊断
- 批准号:
nhmrc : 208978 - 财政年份:2002
- 资助金额:
$ 17.11万 - 项目类别:
Programs
相似国自然基金
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
- 批准号:82371660
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Next Generation Majorana Nanowire Hybrids
- 批准号:
- 批准年份:2020
- 资助金额:20 万元
- 项目类别:
二次谐波非线性光学显微成像用于前列腺癌的诊断及药物疗效初探
- 批准号:30470495
- 批准年份:2004
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes
开发类视黄醇途径的一流拮抗剂作为 2 型糖尿病的新型口服疗法
- 批准号:
10699637 - 财政年份:2023
- 资助金额:
$ 17.11万 - 项目类别:
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
ONC-392首个人体I/II期临床试验:保留CTLA-4免疫耐受检查点,实现更安全、更有效的癌症免疫治疗
- 批准号:
10303238 - 财政年份:2020
- 资助金额:
$ 17.11万 - 项目类别:
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
ONC-392首个人体I/II期临床试验:保留CTLA-4免疫耐受检查点,实现更安全、更有效的癌症免疫治疗
- 批准号:
10010179 - 财政年份:2020
- 资助金额:
$ 17.11万 - 项目类别:
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
ONC-392首个人体I/II期临床试验:保留CTLA-4免疫耐受检查点,实现更安全、更有效的癌症免疫治疗
- 批准号:
10381557 - 财政年份:2020
- 资助金额:
$ 17.11万 - 项目类别:
Cell polarity and generation of the first distinct lineages in the mouse embryo
细胞极性和小鼠胚胎中第一个不同谱系的产生
- 批准号:
243062 - 财政年份:2011
- 资助金额:
$ 17.11万 - 项目类别:
Operating Grants
Cell polarity and generation of the first distinct lineages in the mouse embryo
细胞极性和小鼠胚胎中第一个不同谱系的产生
- 批准号:
208284 - 财政年份:2010
- 资助金额:
$ 17.11万 - 项目类别:
Operating Grants
Cell polarity and generation of the first distinct lineages in the mouse embryo
细胞极性和小鼠胚胎中第一个不同谱系的产生
- 批准号:
210561 - 财政年份:2010
- 资助金额:
$ 17.11万 - 项目类别:
Operating Grants














{{item.name}}会员




